96 related articles for article (PubMed ID: 3790149)
1. In vitro and in vivo studies of a promising antileukemic thymidine analogue, 5-hydroxymethyl-2' deoxyuridine.
Kahilainen L; Bergstrom D; Kangas L; Vilpo JA
Biochem Pharmacol; 1986 Dec; 35(23):4211-5. PubMed ID: 3790149
[TBL] [Abstract][Full Text] [Related]
2. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
3. Antileukemic activity against L1210 leukemia, pharmacokinetics and hematological side effects of 5-hydroxymethyl-2'-deoxyuridine.
Vilpo JA; Suvanto E; Kangas L
Leuk Res; 1987; 11(10):877-80. PubMed ID: 3682866
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxymethyl-2'-deoxyuridine. Cytotoxicity and DNA incorporation studied by using a novel [2-14C]-derivative with normal and leukemic human hematopoietic cells.
Kahilainen LI; Bergstrom DE; Vilpo JA
Acta Chem Scand B; 1985; 39(6):477-84. PubMed ID: 4060961
[TBL] [Abstract][Full Text] [Related]
5. Antitumor cell and antimetabolic effects of 5-ethyl-2'-deoxyuridine and 5'-substituted 5-ethyl-2'-deoxyuridine derivatives.
Balzarini J; De Clercq E; Kiefer G; Keppeler K; Buchele A
Invest New Drugs; 1984; 2(1):35-47. PubMed ID: 6469497
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of 5-hydroxymethyl-2'-deoxyuridine.
Vilpo JA; Suvanto E; Rasi S; Vilpo LM
J Immunol Methods; 1987 Oct; 103(1):41-5. PubMed ID: 3655385
[TBL] [Abstract][Full Text] [Related]
7. Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
Karle JM; Hoerauf RM; Cysyk RL
Cancer Lett; 1983 Jun; 19(2):147-57. PubMed ID: 6883305
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and metabolic actions of 4'-thiothymidine in L1210 cells.
Parker WB; Shaddix SC; Rose LM; Tiwari KN; Montogmery JA; Secrist JA; Bennett LL
Biochem Pharmacol; 1995 Aug; 50(5):687-95. PubMed ID: 7669072
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
Balzarini J; De Clercq E
Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of toxic effects of 5-hydroxymethyl-2'-deoxyuridine in mammalian cells.
Kaufman ER
Somat Cell Mol Genet; 1986 Sep; 12(5):501-12. PubMed ID: 3464103
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of 1,2-dihydro-1-(2-deosy-beta-D-erythro-pentofuranosyl)-2-oxo-5-methylpyrazine 4-oxide, a structural analogue of thymidine.
Bobek M; Boch A; Berkowitz P; Bardos JT
J Med Chem; 1977 Mar; 20(3):458-60. PubMed ID: 321781
[TBL] [Abstract][Full Text] [Related]
12. Lack of specific correlation of the deoxycytidine triphosphate pool level with rate of DNA synthesis.
Walters RA; Ratliff RL
Biochim Biophys Acta; 1975 Dec; 414(3):221-30. PubMed ID: 1203255
[TBL] [Abstract][Full Text] [Related]
13. The human blood platelet: a cellular model to study the degradation of thymidine and its inhibition.
Desgranges C; Razaka G; Rabaud M; Picard P; Dupuch F; Bricaud H
Biochem Pharmacol; 1982 Sep; 31(17):2755-9. PubMed ID: 7138572
[TBL] [Abstract][Full Text] [Related]
14. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
Egan EM; Sargent L; Rosowsky A; Kufe DW
Cancer Treat Rep; 1981; 65(9-10):853-60. PubMed ID: 7273018
[TBL] [Abstract][Full Text] [Related]
15. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Perez LM; Greer S
Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
17. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
Grant S; Rauscher F; Margolin J; Cadman E
Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
[TBL] [Abstract][Full Text] [Related]
18. An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents.
Lazarus HM; Imperia PS; Botti RE; Mack RJ; Lass JH
Lens Eye Toxic Res; 1989; 6(1-2):59-85. PubMed ID: 2488034
[TBL] [Abstract][Full Text] [Related]
19. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
Veselý J; Cihák A
Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
